References
- WashingtonNWashingtonCWilsonCGOcular drug deliveryPhysiological Pharmaceutics: Barriers to Drug Absorption2nd edBoca Raton, FLCRC Press2001249270
- MishimaSGassetAKlyceSDBaumJLDetermination of tear volume and tear flowInvest Ophthalmol1966532642765947945
- ScherzWDoaneMGDohlmanCHTear volume in normal eyes and keratoconjunctivitis siccaAlbrecht Von Graefes Arch Klin Exp Ophthalmol197419221411504548323
- Izazola-CondeCZamora-de La CruzDTenorio-GuajardoGOcular and systemic adverse effects of ophthalmic and non ophthalmic medicationsProc West Pharmacol Soc201154697222423585
- QuarantaLGandolfoFTuranoREffects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucomaInvest Ophthalmol Vis Sci20064772917292316799034
- NovackGDO’DonnellMJMolloyDWNew glaucoma medications in the geriatric population: efficacy and safetyJ Am Geriatr Soc200250595696212028187
- IanchulevTChayetAKahookMPackerMPasqualeLWeinrebRNPharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropperTher Deliv201671175176027733098
- IanchulevTWeinrebRTsaiJCLinSPasqualeLRHigh-precision piezo-ejection microdosing of topical ocular medications: Phase II study on local and systemic effects of phenylephrineTher Deliv201891172729076771
- GuptaRPatilBShahBMEvaluating eye drop instillation technique in glaucoma patientsJ Glaucoma201221318919221336146
- GomesBFParedesAFMadeiraNMoraesHVSanthiagoMRAssessment of eye drop instillation technique in glaucoma patientsArq Bras Oftalmol201780423824128954024
- StoneJLRobinALNovackGDCovertDWCagleGDAn objective evaluation of eyedrop instillation in patients with glaucomaArch Ophthal2009127673273619506189
- HennessyALKatzJCovertDA video study of drop instillation in both glaucoma and retina patients with visual impairmentAm J Ophthalmol2011152698298821821228
- DavisSASleathBCarpenterDMDrop instillation and glaucomaCurr Opin Ophthalmol201829217117729140818
- BurnsEMulleyGPPractical problems with eye-drops among elderly ophthalmology outpatientsAge Ageing19922131681701615776
- JaAKasnerOSamekDALévesqueVEvaluation of eyedrop administration by inexperienced patients after cataract surgeryJ Cataract Refract Surg201440111857186125248295
- GeyerOBottoneEJPodosSMSchumerRAAsbellPAMicrobial contamination of medications used to treat glaucomaBr J Ophthalmol19957943763797742288
- LindénCAlmAThe effect on intraocular pressure of latanoprost once or four times dailyBr J Ophthalmol200185101163116611567957
- LarssonLIntraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center studyActa Ophthalmol Scand200179656757111782220
- van der HeidenHAmarTLichtenauerWFPlasma and ocular pharmacokinetic study comparing 3 µL micro-drop to typical 40 µL drop volume of timolol 0.5% in pigmented rabbitsInvest Ophthalmol Vis Sci201455453
- ElibolOAlçeTYükselNÇaĝlarYThe influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infantsActa Ophthalmol Scand19977521781809197568
- GrayRHThe influence of drop size on pupil dilatationEye1991556156191794430
- BrownRHWoodTSLynchMGImproving the therapeutic index of topical phenylephrine by reducing drop volumeOphthalmology19879478478503658353
- LalAKatariaVRajpalAKhannaNPharmacodynamic effects of pilocarpine eye drop enhanced by decreasing its volume of instillationIndian J Physiol Pharmacol19953932672708550123
- LynchMGBrownRHGoodeSMSchoenwaldRDChienDSReduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorptionArch Ophthal198710510136413653662909